<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1082"/><api:result><api:object category="publication" id="1082" last-affected-when="2024-04-15T01:06:43.32+01:00" last-modified-when="2024-04-15T01:06:43.32+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1082" created-when="2010-05-17T13:47:31.06+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-06-14</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="4194131" source-id="28" source-name="eprints" source-display-name="White Rose Research Online" id-at-source="461" last-modified-when="2022-12-28T12:54:57.313+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Sorsby's fundus dystrophy (SFD) is a dominantly inherited degenerative disease of the retina that leads to loss of vision in middle age. It has been shown to be caused by mutations in the gene for tissue inhibitor of metalloproteinases-3 (TIMP-3). Five different mutations have previously been identified, all introducing an extra cysteine residue into exon 5 (which forms part of the C-terminal domain) of the TIMP-3 molecule; however, the significance of these mutations to the disease phenotype was unknown. In this report, we describe the expression of several of these mutated genes, together with a previously unreported novel TIMP-3 mutation from a family with SFD that results in truncation of most of the C-terminal domain of the molecule. Despite these differences, all of these molecules are expressed and exhibit characteristics of the normal protein, including inhibition of metalloproteinases and binding to the extracellular matrix. However, unlike wild-type TIMP-3, they all form dimers. These observations, together with the recent finding that expression of TIMP-3 is increased, rather than decreased, in eyes from patients with SFD, provides compelling evidence that dimerized TIMP-3 plays an active role in the disease process by accumulating in the eye. Increased expression of TIMP-3 is also observed in other degenerative retinal diseases, including the more severe forms of age-related macular degeneration, the most common cause of blindness in the elderly in developed countries. We hypothesize that overexpression of TIMP-3 may prove to be a critical step in the progression of a variety of degenerative retinopathies. 

</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>PM</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>MD</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M909677199</api:text><api:links><api:link type="doi" href="http://doi.org/10.1074/jbc.M909677199"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M909677199"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1083-351X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Biological Chemistry</api:text></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://www.jbc.org/cgi/content/full/275/35/27027</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>5</api:day><api:month>8</api:month><api:year>2007</api:year></api:date></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>6</api:day><api:month>5</api:month><api:year>2005</api:year></api:date></api:field><api:field name="repository-status" type="text" display-name="Availability"><api:text>Private (withdrawn)</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A Novel Tissue Inhibitor of Metalloproteinases-3 Mutation Reveals a Common Molecular Phenotype in Sorsby's Fundus Dystrophy </api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field><api:files><api:file proprietary-id="https://eprints.whiterose.ac.uk/id/file/6792"><api:filename>barkermd4.pdf</api:filename><api:file-url>https://eprints.whiterose.ac.uk/461/1/barkermd4.pdf</api:file-url><api:extension>pdf</api:extension><api:file-size>153785</api:file-size><api:mime-type>application/pdf</api:mime-type></api:file></api:files></api:native></api:record><api:record format="native" id="4194130" source-id="28" source-name="eprints" source-display-name="White Rose Research Online" id-at-source="453" last-modified-when="2022-12-28T12:54:54.147+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Sorsby’s fundus dystrophy (SFD) is a dominantly inherited
degenerative disease of the retina that leads to
loss of vision in middle age. It has been shown to be
caused by mutations in the gene for tissue inhibitor of
metalloproteinases-3 (TIMP-3). Five different mutations
have previously been identified, all introducing an extra
cysteine residue into exon 5 (which forms part of the
C-terminal domain) of the TIMP-3 molecule; however,
the significance of these mutations to the disease phenotype
was unknown. In this report, we describe the
expression of several of these mutated genes, together
with a previously unreported novel TIMP-3 mutation
from a family with SFD that results in truncation of
most of the C-terminal domain of the molecule. Despite
these differences, all of these molecules are expressed
and exhibit characteristics of the normal protein, including
inhibition of metalloproteinases and binding to
the extracellular matrix. However, unlike wild-type
TIMP-3, they all form dimers. These observations, together
with the recent finding that expression of TIMP-3
is increased, rather than decreased, in eyes from patients
with SFD, provides compelling evidence that
dimerized TIMP-3 plays an active role in the disease
process by accumulating in the eye. Increased expression
of TIMP-3 is also observed in other degenerative
retinal diseases, including the more severe forms of agerelated
macular degeneration, the most common cause
of blindness in the elderly in developed countries. We
hypothesize that overexpression of TIMP-3 may prove to
be a critical step in the progression of a variety of degenerative
retinopathies.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>PM</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>MD</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M909677199</api:text><api:links><api:link type="doi" href="http://doi.org/10.1074/jbc.M909677199"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M909677199"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Biological Chemistry</api:text></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>© 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="public-url" type="text" display-name="Public URL"><api:text>https://eprints.whiterose.ac.uk/id/eprint/453</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://www.jbc.org/cgi/content/full/275/35/27027</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>5</api:day><api:month>8</api:month><api:year>2007</api:year></api:date></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>6</api:day><api:month>5</api:month><api:year>2005</api:year></api:date></api:field><api:field name="repository-status" type="text" display-name="Availability"><api:text>Public</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in sorsby's fundus dystrophy</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field><api:files><api:file proprietary-id="https://eprints.whiterose.ac.uk/id/file/6737"><api:filename>barkermd4.pdf</api:filename><api:file-url>https://eprints.whiterose.ac.uk/453/1/barkermd4.pdf</api:file-url><api:extension>pdf</api:extension><api:file-size>153785</api:file-size><api:mime-type>application/pdf</api:mime-type></api:file></api:files></api:native></api:record><api:record format="native" id="2449177" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1074/jbc.m909677199" last-modified-when="2022-09-11T03:14:48.9+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.m909677199</api:text><api:links><api:link type="doi" href="http://doi.org/10.1074/jbc.m909677199"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.m909677199"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Biological Chemistry</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>14</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published online</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1074/jbc.m909677199</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>4</api:day><api:month>1</api:month><api:year>2021</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A Novel TIMP-3 Mutation Reveals a Common Molecular Phenotype in Sorsby's Fundus Dystrophy</api:text></api:field></api:native></api:record><api:record format="native" id="96135" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034282898" last-modified-when="2023-10-11T07:50:32.747+01:00"><api:citation-count>78</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Sorsby's fundus dystrophy (SFD) is a dominantly inherited degenerative disease of the retina that leads to loss of vision in middle age. It has been shown to be caused by mutations in the gene for tissue inhibitor of metalloproteinases-3 (TIMP-3). Five different mutations have previously been identified, all introducing an extra cysteine residue into exon 5 (which forms part of the C-terminal domain) of the TIMP-3 molecule; however, the significance of these mutations to the disease phenotype was unknown. In this report, we describe the expression of several of these mutated genes, together with a previously unreported novel TIMP-3 mutation from a family with SFD that results in truncation of most of the C-terminal domain of the molecule. Despite these differences, all of these molecules are expressed and exhibit characteristics of the normal protein, including inhibition of metalloproteinases and binding to the extracellular matrix. However, unlike wild-type TIMP-3, they all form dimers. These observations, together with the recent finding that expression of TIMP-3 is increased, rather than decreased, in eyes from patients with SFD, provides compelling evidence that dimerized TIMP-3 plays an active role in the disease process by accumulating in the eye. Increased expression of TIMP-3 is also observed in other degenerative retinal diseases, including the more severe forms of age-related macular degeneration, the most common cause of blindness in the elderly in developed countries. We hypothesize that overexpression of TIMP-3 may prove to be a critical step in the progression of a variety of degenerative retinopathies.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36913712400</api:identifier></api:identifiers></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Newcastle University</api:line><api:line type="city">Newcastle</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56050487600</api:identifier></api:identifiers></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern Genetics Service</api:line><api:line type="city">Newcastle</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57224665684</api:identifier></api:identifiers></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern Genetics Service</api:line><api:line type="city">Newcastle</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005401296</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>PM</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern Genetics Service</api:line><api:line type="city">Newcastle</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7103199686</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>MD</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202354103</api:identifier></api:identifiers></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Victoria Infirmary</api:line><api:line type="city">Newcastle</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55532860900</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M909677199</api:text><api:links><api:link type="doi" href="http://doi.org/10.1074/jbc.M909677199"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M909677199"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10854443</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Biological Chemistry</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in sorsby's fundus dystrophy</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field></api:native></api:record><api:record format="native" id="1082" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10854443" last-modified-when="2021-02-16T23:07:43.433+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Sorsby's fundus dystrophy (SFD) is a dominantly inherited degenerative disease of the retina that leads to loss of vision in middle age. It has been shown to be caused by mutations in the gene for tissue inhibitor of metalloproteinases-3 (TIMP-3). Five different mutations have previously been identified, all introducing an extra cysteine residue into exon 5 (which forms part of the C-terminal domain) of the TIMP-3 molecule; however, the significance of these mutations to the disease phenotype was unknown. In this report, we describe the expression of several of these mutated genes, together with a previously unreported novel TIMP-3 mutation from a family with SFD that results in truncation of most of the C-terminal domain of the molecule. Despite these differences, all of these molecules are expressed and exhibit characteristics of the normal protein, including inhibition of metalloproteinases and binding to the extracellular matrix. However, unlike wild-type TIMP-3, they all form dimers. These observations, together with the recent finding that expression of TIMP-3 is increased, rather than decreased, in eyes from patients with SFD, provides compelling evidence that dimerized TIMP-3 plays an active role in the disease process by accumulating in the eye. Increased expression of TIMP-3 is also observed in other degenerative retinal diseases, including the more severe forms of age-related macular degeneration, the most common cause of blindness in the elderly in developed countries. We hypothesize that overexpression of TIMP-3 may prove to be a critical step in the progression of a variety of degenerative retinopathies.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Oncology &amp; Cellular Pathology, Pathology Section, University of Sheffield, Medical School, Beech Hill Road, Sheffield, S10 2RX, United Kingdom.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>PM</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>MD</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10854443</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M909677199</api:text><api:links><api:link type="doi" href="http://doi.org/10.1074/jbc.M909677199"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M909677199"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Biol Chem</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">COS Cells</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Macular Degeneration</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Pedigree</api:keyword><api:keyword scheme="mesh">Phenotype</api:keyword><api:keyword scheme="mesh">Polymorphism, Single-Stranded Conformational</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Tissue Inhibitor of Metalloproteinase-3</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0021-9258(19)61475-4</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>3</api:day><api:month>10</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field></api:native></api:record><api:record format="native" id="882236" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10854443" last-modified-when="2024-02-13T19:38:28.78+00:00"><api:citation-count>52</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Sorsby's fundus dystrophy (SFD) is a dominantly inherited degenerative disease of the retina that leads to loss of vision in middle age. It has been shown to be caused by mutations in the gene for tissue inhibitor of metalloproteinases-3 (TIMP-3). Five different mutations have previously been identified, all introducing an extra cysteine residue into exon 5 (which forms part of the C-terminal domain) of the TIMP-3 molecule; however, the significance of these mutations to the disease phenotype was unknown. In this report, we describe the expression of several of these mutated genes, together with a previously unreported novel TIMP-3 mutation from a family with SFD that results in truncation of most of the C-terminal domain of the molecule. Despite these differences, all of these molecules are expressed and exhibit characteristics of the normal protein, including inhibition of metalloproteinases and binding to the extracellular matrix. However, unlike wild-type TIMP-3, they all form dimers. These observations, together with the recent finding that expression of TIMP-3 is increased, rather than decreased, in eyes from patients with SFD, provides compelling evidence that dimerized TIMP-3 plays an active role in the disease process by accumulating in the eye. Increased expression of TIMP-3 is also observed in other degenerative retinal diseases, including the more severe forms of age-related macular degeneration, the most common cause of blindness in the elderly in developed countries. We hypothesize that overexpression of TIMP-3 may prove to be a critical step in the progression of a variety of degenerative retinopathies.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Oncology &amp; Cellular Pathology, Pathology Section, University of Sheffield, Medical School, Beech Hill Road, Sheffield, S10 2RX, United Kingdom.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>PM</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>MD</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.m909677199</api:text><api:links><api:link type="doi" href="http://doi.org/10.1074/jbc.m909677199"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.m909677199"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1083-351X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10854443</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of biological chemistry</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">COS Cells</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Macular Degeneration</api:keyword><api:keyword scheme="mesh">Tissue Inhibitor of Metalloproteinase-3</api:keyword><api:keyword scheme="mesh">Pedigree</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Phenotype</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Polymorphism, Single-Stranded Conformational</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>16</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field></api:native></api:record><api:record format="native" id="2509183" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1074654119" last-modified-when="2024-04-15T01:06:43.327+01:00"><api:citation-count>76</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>Kevin P</api:first-names><api:separate-first-names><api:first-name>Kevin</api:first-name><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01074071600.18</api:identifier></api:identifiers></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>Norman</api:first-names><api:separate-first-names><api:first-name>Norman</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Newcastle University</api:line><api:line type="city">Newcastle upon Tyne</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01006450610.09</api:identifier></api:identifiers></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>Anne</api:first-names><api:separate-first-names><api:first-name>Anne</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern Genetics Service, Newcastle upon Tyne, NE2 4AA, United Kingdom, and the</api:line><api:line type="city">Newcastle upon Tyne</api:line><api:line type="state">England</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01100244767.56</api:identifier></api:identifiers></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>Judith A</api:first-names><api:separate-first-names><api:first-name>Judith</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern Genetics Service, Newcastle upon Tyne, NE2 4AA, United Kingdom, and the</api:line><api:line type="city">Newcastle upon Tyne</api:line><api:line type="state">England</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01124626723.02</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>Pat M</api:first-names><api:separate-first-names><api:first-name>Pat</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern Genetics Service, Newcastle upon Tyne, NE2 4AA, United Kingdom, and the</api:line><api:line type="city">Newcastle upon Tyne</api:line><api:line type="state">England</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01214473367.25</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>Michael D</api:first-names><api:separate-first-names><api:first-name>Michael</api:first-name><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.012040106542.36</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>Michael</api:first-names><api:separate-first-names><api:first-name>Michael</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Victoria Infirmary</api:line><api:line type="city">Newcastle upon Tyne</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.011430053302.95</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0021-9258(19)61475-4</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0021-9258(19)61475-4"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0021-9258(19)61475-4"/></api:links></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>10.42</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Biological Chemistry</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3212 Ophthalmology and Optometry</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="rcdc">Macular Degeneration</api:keyword><api:keyword scheme="rcdc">Eye Disease and Disorders of Vision</api:keyword><api:keyword scheme="rcdc">Neurodegenerative</api:keyword><api:keyword scheme="rcdc">Aging</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-hc">Eye</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A Novel Tissue Inhibitor of Metalloproteinases-3 Mutation Reveals a Common Molecular Phenotype in Sorsby's Fundus Dystrophy*</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field></api:native></api:record><api:record format="native" id="242128" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000089144800049" last-modified-when="2024-03-14T05:59:42.1+00:00"><api:citation-count>72</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>PM</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>MD</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000089144800049&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">351EL</api:identifier><api:identifier scheme="pubmed">10854443</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF BIOLOGICAL CHEMISTRY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in sorsby's fundus dystrophy</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field></api:native></api:record><api:record format="native" id="25344" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000089144800049" last-modified-when="2014-07-28T06:29:50.08+01:00"><api:citation-count>43</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Langton</api:last-name><api:initials>KP</api:initials><api:first-names>KP</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>McKie</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Curtis</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goodship</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bond</api:last-name><api:initials>PM</api:initials><api:first-names>PM</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1773" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1773"/></api:links><api:last-name>Barker</api:last-name><api:initials>MD</api:initials><api:first-names>MD</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Clarke</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>35</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J BIOL CHEM</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>RETINITIS-PIGMENTOSA</api:keyword><api:keyword>PROGELATINASE-A</api:keyword><api:keyword>TERMINAL DOMAIN</api:keyword><api:keyword>IV COLLAGENASE</api:keyword><api:keyword>CELL-DEATH</api:keyword><api:keyword>TIMP-3</api:keyword><api:keyword>EXPRESSION</api:keyword><api:keyword>CLONING</api:keyword><api:keyword>GENE</api:keyword><api:keyword>ACTIVATION</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>27027</api:begin-page><api:end-page>27031</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in sorsby's fundus dystrophy</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>275</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">COS Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Macular Degeneration</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mutation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pedigree</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Phenotype</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Polymorphism, Single-Stranded Conformational</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Protein Conformation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tissue Inhibitor of Metalloproteinase-3</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">COS Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Macular Degeneration</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tissue Inhibitor of Metalloproteinase-3</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pedigree</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Protein Conformation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Phenotype</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mutation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Polymorphism, Single-Stranded Conformational</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3212 Ophthalmology and Optometry</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Macular Degeneration</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Eye Disease and Disorders of Vision</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Neurodegenerative</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Aging</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Eye</api:keyword><api:keyword origin="record-data" source="wos">RETINITIS-PIGMENTOSA</api:keyword><api:keyword origin="record-data" source="wos">PROGELATINASE-A</api:keyword><api:keyword origin="record-data" source="wos">TERMINAL DOMAIN</api:keyword><api:keyword origin="record-data" source="wos">IV COLLAGENASE</api:keyword><api:keyword origin="record-data" source="wos">CELL-DEATH</api:keyword><api:keyword origin="record-data" source="wos">TIMP-3</api:keyword><api:keyword origin="record-data" source="wos">EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">CLONING</api:keyword><api:keyword origin="record-data" source="wos">GENE</api:keyword><api:keyword origin="record-data" source="wos">ACTIVATION</api:keyword><api:keyword scheme="for" origin="issn-inferred">03 Chemical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">06 Biological Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">11 Medical and Health Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Biochemistry &amp; Molecular Biology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">31 Biological sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">32 Biomedical and clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">34 Chemical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0021-9258" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965625" title="Journal of Biological Chemistry"><api:records><api:record source-name="summary"><api:title>Journal of Biological Chemistry</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1082/relationships"/></api:object></api:result></api:response>